Interneuron Transplantation as a Treatment for Epilepsy
Robert F Hunt1, Scott C Baraban1
1Department of Anatomy & Neurobiology, University of California Irvine, Irvine, California 92697.
Cold Spring Harbor Perspectives in Medicine
|December 3, 2015
Summary
Stem-cell therapy shows promise for epilepsy by transplanting young inhibitory interneurons. These cells integrate into the brain, reduce seizures, and offer hope for treating neurological disorders.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Epilepsy Research
Background:
- Epilepsy presents significant unmet therapeutic needs.
- Enhancing brain inhibition is a key strategy for seizure control.
- Cortical interneurons play a crucial role in regulating neuronal activity.
Purpose of the Study:
- To review the potential of stem-cell-based therapy for epilepsy.
- To explore the transplantation of inhibitory cortical interneurons.
- To discuss challenges in developing stem-cell treatments for epilepsy.
Main Methods:
- Review of recent research on isolating and transplanting cortical interneuron precursors.
- Analysis of embryonic mouse and human cell sources for transplantation.
- Evaluation of the functional integration and seizure-stopping capabilities of grafted interneurons.
Main Results:
- Embryonic γ-aminobutyric acid (GABA)ergic precursors can disperse and mature into host brain circuits.
- Transplanted interneurons functionally integrate as local-circuit interneurons.
- Grafted interneurons have demonstrated seizure reduction in both genetic and acquired epilepsy models.
Conclusions:
- Interneuron cell transplantation is a promising approach for intractable epilepsies.
- This strategy may also benefit other brain disorders with epilepsy comorbidity.
- Further research is needed to overcome challenges for clinical application in human epilepsy.
